Arnaub Chatterjee is President and General Manager of Life Sciences, Ecosystem and Public Sector at Datavant where he is charged with leading the organization's efforts to transform the development and access to new medicines through data platforms and technology. Prior to Datavant, Arnaub served as Chief Product and Solutions Officer at TriNetX, a health technology platform focused on improving clinical trial design and patient recruitment. He also served as Senior Vice President and head of Acorn AI, the data science business of Medidata Solutions. Prior to Medidata, he worked in various leadership capacities at McKinsey & Company, Merck and the Obama Administration.
Arnaub is passionate about teaching and is a member of the faculty in the Department of Health Care Policy at Harvard Medical School. He is a member of the Board of Directors of MJH Life Sciences, the largest privately-held medical media company in the United States; BioSpring, a life sciences growth equity firm; and the Alliance for Artificial Intelligence in Healthcare (AAIH). He has published in multiple peer-reviewed journals such as the Harvard Business Review and Nature and has presented at conferences ranging from South by Southwest to the American College of Cardiology. He holds masters degrees in health administration (MHA) and public administration (MPA) from Cornell University and a BS in Molecular Biology from the University of Michigan.
